期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

外周血NLR与PLR对原发性胃癌患者生存状况的评估价值 被引量：8

Value of peripheral NLR and PLR for the survival of patients with primary gastric cancer
下载PDF
导出
摘要 目的探讨原发性胃癌患者入院时中性粒细胞与淋巴细胞比值(neutrophil-to-lymphocyte ratio,NLR)和血小板与淋巴细胞比值(platelet-to-lymphocyte ratio,PLR)对胃癌患者生存预后的预测价值。方法分析132例原发性胃癌患者及30例健康对照的临床资料,采用Kaplan-Meier、Log-rank检验、多元COX回归分析胃癌患者的生存状况。结果病例组NLR、PLR水平均明显高于健康对照组(t=6.67,P=0.000;t=13.23,P=0.000);年龄越高、肿瘤直径越大、临床分期越高、分化程度越差、出现淋巴结转移及未进行手术治疗NLR、PLR有升高的趋势(P<0.05);NLR与PLR呈明显的正相关关系(r=0.3164,P=0.0002);低NLR组生存时间为(57.59±2.23)月(中位生存时间为55个月),高NLR组生存时间为(35.22±3.09)月(中位生存时间为37个月),2者差异有统计学意义(χ2=6.298,P=0.0361);低PLR组生存时间为(54.09±2.66)月(中位生存时间为54个月),高PLR组生存时间为(35.22±2.75)月(中位生存时间为37个月),2者差异有统计学意义(χ2=5.879,P=0.0377)。胃癌患者总体生存期的独立影响因素有年龄、临床分期、有无淋巴结转移及NLR、PLR水平(P<0.05)。结论胃癌患者NLR、PLR显著升高,与患者的年龄、肿瘤大小、转移程度、临床分期等密切相关,并且对于患者的生存预后变差具有一定的预测价值。 Objective To investigate value of peripheral NLR and PLR for the survival of patients with primary gastric cancer. Methods The clinical data of 132 primary gastric cancer patients and 30 healthy controls were analyzed by the Kaplan-Meier,Log-rank test and multivariate COX regression. Results NLR,PLR levels of the case group were significantly higher than that in the healthy control group（ t = 6. 67,P = 0. 000; t = 13. 23,P = 0. 000）; the higher the age,the greater tumor diameter,the higher the degree of differentiation,lymph node metastasis,and not be treated with surgery,NLR and PLR could increase（ P〈0. 05）; NLR and PLR showed a significant positive correlation（ r = 0. 3164,P = 0. 0002）; survival time of low NLR group was（ 57. 59 ± 2. 23） months and high NLR group was（ 35. 22 ± 3. 09） months（ P〈0. 05）; survival time of low PLR group was（ 54. 09± 2. 66） months and high PLR group was（ 35. 22 ± 2. 75） months（ P〈0. 05）; age,clinical stage,lymph node metastasis and NLR,PLR levels were independent factors for the overall survival in patients with gastric cancer（ P〈0. 05）. Conclusion NLR and PLR of gastric cancer patients increase significantly and are closely related to tumor size,metastasis,clinical stage,and the deterioration,which showes some predictive value for the survival prognosis of the patients.
作者 陈志奇 刘朔婕 陈波
机构地区 厦门大学附属第一医院检验科
出处 《中国生化药物杂志》 CAS 2015年第9期103-105,108,共4页 Chinese Journal of Biochemical Pharmaceutics
关键词 原发性胃癌 中性粒细胞与淋巴细胞比值(NLR) 血小板与淋巴细胞比值(PLR) 生存预后 primary gastric cancer neutrophil and lymphocyte ratio（NLR） platelet and lymphocyte ratio（PLR） survival prognosis
分类号 R735.34 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1陈万青,郑荣寿,曾红梅,张思维,赵平,赫捷.1989-2008年中国恶性肿瘤发病趋势分析[J].中华肿瘤杂志,2012,34(7):517-524. 被引量：201
  • 2Suzuki K, Kachala SS,Kadota K,et al. Prognostic immune markers innon -small cell lung cancer [ J ]. Clin Cancer Res,2011,17 ( 16 ):5247-5256.
  • 3Wei K, Wang M, Zhang W, et al. Neutrophil-lymphocyte ratio as apredictor of outcomes for patients with hepatocellular carcinomaundergoing TAE combined with Sorafenib [ J ] . Med Oncol, 2014, 31(6): 969.
  • 4王智,马晋平,林建伟,陈创奇,蔡世荣,何裕隆.术前中性粒细胞与淋巴细胞比值与结直肠癌患者预后的关系[J].消化肿瘤杂志（电子版）,2011,3(4):246-250. 被引量：17
  • 5李书梅,徐小莉,梁迪,田国,宋珊,贺宇彤.外周血中性粒细胞与淋巴细胞比值以及血小板与淋巴细胞比值评估胃癌患者预后的价值[J].中华肿瘤杂志,2014,36(12):910-915. 被引量：46
  • 6Lee S,Oh SY,Kim SH, et al. Prognostic significance of neutmphillymphocyte ratio and platelet lymphocyte ratio in advanced gastriccancer patients treated with FOLFOX chemotherapy [ J ] . BMC Cancer,2013,13: 350.
  • 7Tazzyman S,Barry ST,Ashton S,et al. Inhibition of neutrophilinfiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth [ J] . Int JCancer, 2011, 129(4) : 847-858.
  • 8Arab B, Bhatt VR, et al. Usefulness ofthe neutmphil-tolymphocyte ratioin predicting short-and long-term mortality in breast cancer patients [ J ].Ann Surg Oncol, 2012,19(1) ; 217-224.
  • 9Pichler M,Hutterer GC,Stoeckigt,et al. Validation of the pretreatmentneutrophil lymphocyte ratio as a prognostic factor in a large Europeaneohort of renal cell carcinoma patients [ J ]. Br J Cancer, 2013,108(4); 901-907.
  • 10Dutta S, Crundey AB, Fullarton GM, et al. Comparison of theprognostic value of tumour and patient related factors in patientsundergoing potentially curative resection of gastric cancer [ J ]. Am JSurg, 2012, 204(3) : 294-299.

二级参考文献43

  • 1赫捷,赵平,陈万青.2011中国肿瘤登记年报.北京:军事医学科学出版社,2011:20-23.
  • 2Jensen OM, Parkin DM, Maclennan R, et al. Cancer registration principles and methods. IARC Sci Pub No. 95. Lyon: IARC, 1991:101-107.
  • 3Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. Lyon: IARC, 1994:35-49.
  • 4Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000, 19 : 335-351.
  • 5Eheman C, Henley SJ, Ballard-Barbash R, et al. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer, 2012, 118:2338-2366.
  • 6Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions ( risk factors, screening, and treatment) to reduce future rates. Cancer, 2010, 116:544- 573.
  • 7Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population- based trends in cancer treatment. J Natl Cancer Inst, 2005, 97 : 1407-1427.
  • 8Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U. S. cancer burden. Cancer; 2002, 94: 2766-2792.
  • 9Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst, 2008, 100: 1672-1694.
  • 10Hanahan D,Weinberg RA. Hallmarks of Cancer:The Next Generation[J].{H}CELL,2011,(05):646-674.

共引文献260

同被引文献74

引证文献8

二级引证文献41

中国生化药物杂志
2015年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部